Daily Digest — September 21, 2026
A gene therapy restores night vision, Chile eliminates dog rabies, and a record year for renewables.
Subject: A gene therapy restores night vision + 4 more stories of progress
Preview text: The first successful pivotal trial for a blinding eye disease, Chile eliminates dog rabies, and a record year for renewables.
Good morning. Here's what's going right.
🌟 Today's Lead
First Successful Pivotal Gene Therapy for a Blinding Eye Disease Restores Night Vision
Beacon Therapeutics' gene therapy laru-zova has become the first treatment for X-linked retinitis pigmentosa to succeed in a pivotal trial. After one year, 31% of high-dose patients and 24% of low-dose patients gained 15 or more letters on a low-light vision test. None of the untreated control group did.
XLRP mainly affects boys and young men, stealing night vision first and often progressing toward blindness. Earlier gene-therapy programmes in this disease failed or mixed their endpoints. Beacon plans a rolling regulatory filing by the end of 2026. It is not a cure for everyone in the trial — most patients did not hit the 15-letter bar, and the procedure is surgical — but it is the first time this condition has a late-stage win.
In Brief
🌎 Chile Becomes First South American Country to Eliminate Dog-Transmitted Rabies
WHO has validated Chile as the first country in South America — and only the third in the world after Mexico and Bhutan — to eliminate dog-transmitted rabies as a public health problem. Chile's last human case was in 1972. Validation required working surveillance, laboratories, mass pet vaccination, and post-exposure treatment, not just a quiet statistic. Human dog-mediated rabies in the Americas has fallen more than 98% since 1983.
☀️ The World Added a Record 693 Gigawatts of Renewables in 2025
IRENA reported a record 693 GW of new renewable power last year, taking total capacity to 5.15 TW — about half of all global power capacity. UN climate chief Simon Stiell said the boom avoided almost US$500 billion in fossil fuel costs. If 2025's growth holds, the world would reach about 10.6 TW by 2030, closing most of the gap to the COP28 tripling target.
📚 UNESCO Honours Six Literacy Programmes Changing Lives From Beirut to Nigeria
UNESCO's 2026 literacy prizes honoured programmes that can name their outcomes. In Beirut's Shatila camp, Wissal, a Syrian refugee who could not read at 12, is preparing a psychology degree in Canada. In a Nigerian conflict zone, 12-year-old Chisom wrote "Book and Peace," now reads fluently, and helps lead a Canoe Library.
🧬 Epigenetic Editing Shuts Down Hepatitis B Without Cutting DNA
Scientists at nChroma Bio tagged hepatitis B viral DNA with chemical silencers rather than cutting the genome. Results in cells and mice were strong after a single injection; a human trial has already begun. Chronic HBV affects more than 250 million people, and existing drugs rarely clear the reservoir.
📊 Progress by Numbers
- 31% of high-dose XLRP patients gained 15+ letters of night vision versus 0% of controls
- 693 GW of renewables added in 2025 — more than half of US generating capacity
- Almost US$500 billion in fossil fuel costs avoided last year
- 50 years since Chile's last human case of dog-mediated rabies
- First new wild cat species identified in 100 years, in Bolivia's Yungas
💡 One Thing You Can Do
If you keep a dog or cat, check that their rabies vaccination is current. Chile's milestone was built on ordinary, repeated, unglamorous vaccination campaigns — the same tool that still saves lives everywhere the disease has not been eliminated.
Bright Side Daily delivers proof that progress is happening every day. Full stories and sources: thebrightside.news
Also today: COMP360 psilocybin Phase 3 · New wild cat species